These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9544217)

  • 21. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R; Alanine A; Bourson A; Buttelmann B; Fischer G; Heitz MP; Kew JN; Levet-Trafit B; Lorez HP; Malherbe P; Miss MT; Mutel V; Pinard E; Roever S; Schmitt M; Trube G; Wybrecht R; Wyler R; Kemp JA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of NMDA receptor subtype NR2B prevents seizures but not apoptosis of dentate gyrus neurons in bacterial meningitis in infant rats.
    Kolarova A; Ringer R; Täuber MG; Leib SL
    BMC Neurosci; 2003 Sep; 4():21. PubMed ID: 13129439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CP-101606 Pfizer Inc.
    Chazot PL
    Curr Opin Investig Drugs; 2000 Nov; 1(3):370-4. PubMed ID: 11249721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.
    Banerjee A; Schepmann D; Köhler J; Würthwein EU; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):7855-67. PubMed ID: 20965735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonists selective for NMDA receptors containing the NR2B subunit.
    Chenard BL; Menniti FS
    Curr Pharm Des; 1999 May; 5(5):381-404. PubMed ID: 10213801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
    Barton ME; White HS; Wilcox KS
    Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
    Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
    Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
    Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B
    Bioorg Med Chem; 2010 Nov; 18(22):8005-15. PubMed ID: 20965739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits.
    Boeckman FA; Aizenman E
    J Pharmacol Exp Ther; 1996 Nov; 279(2):515-23. PubMed ID: 8930153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NMDA NR2B subunit-selective receptor antagonist, CP-101,606, enhances the functional recovery the NMDA NR2B subunit-selective receptor and reduces brain damage after cortical compression-induced brain ischemia.
    Kundrotiene J; Cebers G; Wägner A; Liljequist S
    J Neurotrauma; 2004 Jan; 21(1):83-93. PubMed ID: 14987468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).
    Sun L; Chiu D; Kowal D; Simon R; Smeyne M; Zukin RS; Olney J; Baudy R; Lin S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):563-70. PubMed ID: 15075380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats.
    Wessell RH; Ahmed SM; Menniti FS; Dunbar GL; Chase TN; Oh JD
    Neuropharmacology; 2004 Aug; 47(2):184-94. PubMed ID: 15223297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.
    Ma YY; Guo CY; Yu P; Lee DY; Han JS; Cui CL
    Exp Neurol; 2006 Aug; 200(2):343-55. PubMed ID: 16631172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of N-methyl-D-aspartate receptor subunits responsible for postoperative pain.
    Nishimura W; Muratani T; Tatsumi S; Sakimura K; Mishina M; Minami T; Ito S
    Eur J Pharmacol; 2004 Oct; 503(1-3):71-5. PubMed ID: 15496298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist.
    Taniguchi K; Shinjo K; Mizutani M; Shimada K; Ishikawa T; Menniti FS; Nagahisa A
    Br J Pharmacol; 1997 Nov; 122(5):809-12. PubMed ID: 9384494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro opioid receptor functional antagonism of analogues of the selective kappa opioid receptor antagonist (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
    Cai TB; Zou Z; Thomas JB; Brieaddy L; Navarro HA; Carroll FI
    J Med Chem; 2008 Mar; 51(6):1849-60. PubMed ID: 18307295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.